Use access key #2 to skip to page content.
$69.08 -0.55 (-0.79%)
5/16/2008 4:00 PM

Genzyme Corp (GENZ)

CAPS Rating:
*****

A biotechnology company dedicated to making an impact on the lives of people with serious diseases. Its product and service portfolio is focused on rare disorders, renal diseases, orthopaedics, organ transplant, and diagnostic and predictive testing.

View All Commentary (GENZ)

Recs

0

Avatar jchallis (63.93) Submitted: 3/23/08 3:19 PM : Outperform Start Price: $71.97 GENZ Score: -11.03

This company has a great competitive advantage -- they produce life-saving drugs for relatively rare diseases. Being low volume, they can continue to hold their niche against big players. Having been in the game for over 25 years, they can hold their own against newcomers. You gotta love that drug pipeline...

Report this Post Replies: 0 | Reply

Featured Broker Partners